Foto del docente

Andrea Ardizzoni

Professore ordinario

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: MEDS-09/A Oncologia medica

Pubblicazioni

Monetti F; Casanova S; Grasso A; Cafferata MA; Ardizzoni A; Neumaier CE, Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases, «LUNG CANCER», 2004, 43, pp. 71 - 74 [replica/breve intervento]

Merisio C; Bozzetti C; Bortesi B; Capelletti M; Bella MA; Zanelli P; Neri TM; Melpignano M; Cascinu S; Ardizzoni A, LOSS OF HETEROZYGOSITY (LOH) IN OVARIAN CANCER, «ANNALS OF ONCOLOGY», 2004, 15, pp. 45 - 45 [abstract]

Sgargi P; Michiara M; Bella MA; Musolino A; Naldi N; Zanelli P; Cappelletti M; Bortesi B; Ardizzoni A; De Lisi V, MULTIPLE COLORECTAL-ENDOMETRIAL (CEC) AND YOUNG AGE ONSET ENDOMETRIAL CANCER (EC): ARE THEY A FAMILY MARKER FOR HEREDITARY NON-POLYPOSIS COLORECTAL CARCINOMA SYNDROME (HNPCC)?, «ANNALS OF ONCOLOGY», 2004, 15, pp. 64 - 64 [abstract]

Ardizzoni A; Tiseo M, Predictors of clinical response of non-small cell cancer to gefitinib, «JAMA», 2004, 291, pp. 1563 - 1563 [replica/breve intervento]

Gatzemeier U; Groth G; Butts C; Van Zandwijk N; Shepherd F; Ardizzoni A; Barton C; Ghahramani P; Hirsh V, Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer, «ANNALS OF ONCOLOGY», 2004, 15, pp. 19 - 27 [replica/breve intervento]

Ardizzoni A; Tiseo M, Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC), «JOURNAL OF CHEMOTHERAPY», 2004, 16, pp. 104 - 107 [replica/breve intervento]

Ardizzoni A, Topotecan in the treatment of recurrent small cell lung cancer: An update, «THE ONCOLOGIST», 2004, 9, pp. 4 - 13 [replica/breve intervento]

Gridelli C; Ardizzoni A; Le Chevalier T; Manegold C; Perrone F; Thatcher N; van Zandwijk N; Di Maio M; Martelli O; De Marinis F, Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel, «ANNALS OF ONCOLOGY», 2004, 15, pp. 419 - 426 [replica/breve intervento]